A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
- Ann. Oncol., Available online 3 December 2020 | https://doi.org/10.1016/j.annonc.2020.11.017
